Public Company News
ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
Financial Highlights: * 22.2% Increase in Q4 2023 Revenue Compared to Q4 2022; 2.6% Increase Compared to Q3 2023; Full Year 2023 Revenue Declines 9.2% Compared to Prior Year * 560 Basis Point Increase in Q4 2023 Gross Margin Compared to Q4 2022, and 420 Basis Point Increase Compared to Q3 2023...
2024-02-22 15:00
3665
NaaS Technology Awarded by CDP a Global Above-average ESG Performance Rating
BEIJING, Feb. 22, 2024 /PRNewswire/ -- Global Environmental Information Research Center CDP (formerly known as Carbon Disclosure Project), also a leading global carbon emissions rating agency, has recently announced its latest CDP Score Report. NaaS Technology (NASDAQ: NAAS), participating for th...
2024-02-22 14:59
3675
Trip.com Group Limited Reports Unaudited Fourth Quarter and Full Year of 2023 Financial Results
SHANGHAI, Feb. 21, 2024 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announced its un...
2024-02-22 06:00
4326
CHINA NATURAL RESOURCES, INC. ANNOUNCES THE CLOSING OF REGISTERED DIRECT PLACEMENT OF $3.27 MILLION OF COMMON SHARES AND PRIVATE PLACEMENT WARRANTS
HONG KONG, Feb. 21, 2024 /PRNewswire/ -- CHINA NATURAL RESOURCES, INC. (NASDAQ: CHNR) (the "Company") today announced that it closed the registered direct placement of approximately$3.27 million of common shares at a price of $2.20 per share onFebruary 21, 2024, as previously announced on Februar...
2024-02-22 05:30
2382
Antelope Enterprise Announces Warrant Exchange Agreements
CHENGDU, China, Feb. 21, 2024 /PRNewswire/ -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) ("Antelope Enterprise" or the "Company"), which operates Kylin Cloud, a livestreaming ecommerce business inChina with access to 800,000+ anchors and influencers, announced today that o...
2024-02-22 05:15
3996
Mabwell Publishes the Phase III Study Results on Its Denosumab Biosimilar (MW032) in the journal JAMA Oncology
SHANGHAI, Feb. 21, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, recently published the phase III study results of denosumab biosimilar (MW032) online in the international top journal of JAMA Oncology. This is the first recorded tria...
2024-02-21 22:00
2197
SunCar Technology Group Inc. Announces Business Cooperation with Li Auto for Advanced System Software Development
NEW YORK, Feb. 21, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in digitalized automotive after-sales services and online auto insurance intermediation inChina , today announced a new business cooperation (the "Agreement") throug...
2024-02-21 20:30
3779
Origin Agritech Grows Revenue by 77% Year-Over-Year, Records Net Income of $8.7 Million
Announces Filing of Annual Report on Form 20-F for Fiscal Year 2023 BEIJING, Feb. 21, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial results for the year endedSeptember 30, 2023. M...
2024-02-21 20:00
3786
WuXi Biologics Recognized as Both Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics
* Named Top-Rated for fourth consecutive year * Committed to generating long-term value for all stakeholders SHANGHAI, Feb. 21, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has ...
2024-02-21 18:00
3785
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
HANGZHOU, China, Feb. 20, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and Prevention in theUnited Arab Emirates for five of i...
2024-02-21 16:16
2139
U Power Limited Receives Nasdaq Delisting Notification and Intends to Appeal
SHANGHAI, Feb. 20, 2024 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider inChina, today announced that onFebruary 14, 2024, it received a notification lett...
2024-02-21 05:30
3700
Infobird Co., Ltd Announces 1-for-8 Share Consolidation and Capital Reduction
HONG KONG, Feb. 20, 2024 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of innovative AI-powered, or artificial intelligence enabled, customer engagement solutions, today announced that the extraordinary general meetings of the sha...
2024-02-21 00:15
3996
Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
CHENGDU, China, Feb. 20, 2024 /PRNewswire/ -- Hox Therapeutics Ltd ("Hox") a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a collaboration to identify inhibitors again...
2024-02-20 22:30
2540
Senmiao Technology's XXTX Online Ride-hailing Platform Receives Highest Rating for Service Quality and Reputation in Changsha
CHENGDU, China, Feb. 20, 2024 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced that the Comp...
2024-02-20 22:00
2630
FDA Grants Orphan Drug Designation to 9MW3011
SHANGHAI, Feb. 20, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that FDA has granted Orphan Drug Designation (ODD) to 9MW3011 (R&D code in the US: MWTX-003/DISC-3405) for the treatment of patients with polycythemia vera (P...
2024-02-20 22:00
2128
Mabwell Receives IND Approval from FDA for Novel B7-H3 ADC 7MW3711
SHANGHAI, Feb. 20, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of B7-H3 targeting ADC (R&D code: 7MW3711) for advanced malignant solid tumor was approved by the U.S. Food and Drug Admi...
2024-02-20 22:00
2199
One of the World's Top 5 Freight Services Company Selects SU Group for Enhanced Threat Detection
HONG KONG, Feb. 20, 2024 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company inHong Kong, today announced that one of the world's top 5 freight services company has selected SU Group for a state-of-the...
2024-02-20 21:00
3952
WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI™ (lifileucel) for Advanced Melanoma
AMTAGVI is the first and only one-time, individualized T cell therapy to receive U.S. FDA approval fora solid tumor cancer. PHILADELPHIA, Feb. 20, 2024 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced that the U.S. Food and Drug Admini...
2024-02-20 21:00
4356
Origin Agritech Regains Compliance with Nasdaq Listing Standards
BEIJING, Feb. 20, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced that it has regained compliance with Nasdaq's market value of listed securities requirement as set forth in Listing Rule 5550(...
2024-02-20 20:00
3277
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
BEIJING, Feb. 20, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it has received a letter (the "Letter") from t...
2024-02-20 20:00
3455
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 310 media titles]
2026-03-18 12:00
HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 302 media titles]
2026-03-20 09:36
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
[Picked up by 301 media titles]
2026-03-17 08:00Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 297 media titles]
2026-03-18 08:00
Agoda and Gangwon State Join Hands to Elevate Gangwon into a Premier Global Travel Destination
[Picked up by 295 media titles]
2026-03-17 11:29
Most Read
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
2026-03-17 08:00
7015
H World Group Reports Strong Full-Year 2025 Results, Driven by Asset-light Growth
2026-03-18 21:05
6664
Yunji Technology: AI Agent Revenue Soars Nearly 3x, HDOS Clients Surge 925%
2026-03-17 11:16
6255
